Literature DB >> 15250036

Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose.

E Beltramo1, E Berrone, S Buttiglieri, M Porta.   

Abstract

BACKGROUND: High glucose induces pathological alterations in small and large vessels, possibly through increased formation of AGE, activation of aldose reductase and protein kinase C, and increased flux through the hexosamine pathway. We showed previously that thiamine and benfotiamine correct delayed replication and increase lactate production in endothelial cells subjected to high glucose. We now aim at verifying the effects of thiamine and benfotiamine on cell cycle, apoptosis, and expression of adhesion molecules in endothelial cells and pericytes, under high ambient glucose.
METHODS: Human umbilical vein endothelial cells and bovine retinal pericytes were cultured in normal (5.6 mmol/L) or high (28 mmol/L) glucose, with or without thiamine or benfotiamine, 50 or 100 micro mol/L. Apoptosis was determined by two separate ELISA methods, measuring DNA fragmentation and caspase-3 activity, respectively. Cell cycle and integrin subunits alpha3, alpha5, and beta1 concentration were measured by flow cytometry.
RESULTS: Apoptosis was increased in high glucose after 3 days of culture, both in endothelium and pericytes. Thiamine and benfotiamine reversed such effects. Neither cell cycle traversal nor integrin concentrations were modified in these experimental conditions.
CONCLUSIONS: Thiamine and benfotiamine correct increased apoptosis due to high glucose in cultured vascular cells. Further elucidations of the mechanisms through which they work could help set the basis for clinical use of this vitamin in the prevention and/or treatment of diabetic microangiopathy. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15250036     DOI: 10.1002/dmrr.470

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  14 in total

1.  Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects.

Authors:  Howard A Smithline; Michael Donnino; David J Greenblatt
Journal:  BMC Clin Pharmacol       Date:  2012-02-04

2.  Anti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages.

Authors:  Mohammad Shoeb; Kota V Ramana
Journal:  Free Radic Biol Med       Date:  2011-10-24       Impact factor: 7.376

Review 3.  Metabolic and structural role of thiamine in nervous tissues.

Authors:  Abdoulaye Bâ
Journal:  Cell Mol Neurobiol       Date:  2008-07-19       Impact factor: 5.046

4.  Protective role of benfotiamine, a fat-soluble vitamin B1 analogue, in lipopolysaccharide-induced cytotoxic signals in murine macrophages.

Authors:  Umesh C S Yadav; Nilesh M Kalariya; Satish K Srivastava; Kota V Ramana
Journal:  Free Radic Biol Med       Date:  2010-02-26       Impact factor: 7.376

5.  Uncovering the beginning of diabetes: the cellular redox status and oxidative stress as starting players in hyperglycemic damage.

Authors:  João Soeiro Teodoro; Ana Patrícia Gomes; Ana Teresa Varela; Filipe Valente Duarte; Anabela Pinto Rolo; Carlos Marques Palmeira
Journal:  Mol Cell Biochem       Date:  2013-01-08       Impact factor: 3.396

6.  Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.

Authors:  Ari Moskowitz; Lars W Andersen; Michael N Cocchi; Mathias Karlsson; Parth V Patel; Michael W Donnino
Journal:  Ann Am Thorac Soc       Date:  2017-05

7.  NADPH Oxidase versus Mitochondria-Derived ROS in Glucose-Induced Apoptosis of Pericytes in Early Diabetic Retinopathy.

Authors:  Nik M Mustapha; Joanna M Tarr; Eva M Kohner; Rakesh Chibber
Journal:  J Ophthalmol       Date:  2010-06-28       Impact factor: 1.909

8.  The impact of thiamine treatment in the diabetes mellitus.

Authors:  Khanh Vinh Quoc Luong; Lan Thi Hoang Nguyen
Journal:  J Clin Med Res       Date:  2012-05-15

9.  A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives.

Authors:  Derrick Lonsdale
Journal:  Evid Based Complement Alternat Med       Date:  2006-03       Impact factor: 2.629

10.  Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives.

Authors:  Marie-Laure Volvert; Sandrine Seyen; Marie Piette; Brigitte Evrard; Marjorie Gangolf; Jean-Christophe Plumier; Lucien Bettendorff
Journal:  BMC Pharmacol       Date:  2008-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.